Enzo Biochem, Inc. (NYSE:ENZ)

CAPS Rating: 2 out of 5

The Company is a life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and a provider of diagnostic services to the medical community.

Recs

0
Player Avatar marv818 (< 20) Submitted: 12/24/2007 10:32:01 PM : Outperform Start Price: $14.40 ENZ Score: -78.86

The company will be sold within several months

Featured Broker Partners


Advertisement